🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share comparison images, injection guides and assertions of rapid British shipping. Sellers market the drug there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in users injecting products of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer laws, risking fines, legal action or prison.

Platform Response and Content Removal

According to the social media company, the platform has removed violative content and banned related hashtags and query recommendations. The company said it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Online Trading Operations

Investigations also discovered groups with up to nine thousand members marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, glowing reviews and step-by-step guides for mixing or injecting at home.

After moments of joining one group, a seller shared contact information, where most transactions take place. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Information and Costs

Inside these groups, messages show dark colored packages with postal service labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how long a pen should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has already seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to potentially significant medical dangers”.